Tag: MBD4

ICARE Newsletter Fall 2026

National Comprehensive Cancer Network (NCCN) Guidelines Update: Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, Esophageal, and Gastric (Version 1.2026)

The panel set a specific minimal set of genes to test for colorectal, endometrial, and gastric cancer: COLORECTAL CANCER GENES(including genes that predispose to polyps) Additional genes that sometimes get included: ATM, BLM, CHEK2, GALNT12, RNF43, and RPS20. ENDOMETRIAL (UTERINE) CANCER GENES GASTRIC CANCER GENES Test selection and decision to retest including additional genes beyond these …

Continue reading

Permanent link to this article: https://inheritedcancer.net/nlf20262/

ICARE Social Media Post March 2023

New gene alert: MBD4

A new study shows germline MBD4 mutations cause an autosomal recessive tumor predisposing syndrome associated with: This highlights the importance of including MBD4 in genetic testing for polyposis and multi-tumor phenotypes to improve disease management. Use the link in bio to learn more! Reference: Palles, et al. Am J Hum Genet. 2022;109(5):953-960. PMID: 35460607.

Permanent link to this article: https://inheritedcancer.net/post31223/